Source: Annual Congress 2002 - Airway reactivity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Ward, D. Reid, M. Pais, B. Orsida, B. Feltis, R. Bish, D. Johns, E. H. Walters (Newcastle upon Tyne, United Kingdom; Hobart, Melbourne, Australia). PD20 to methacholine is predicted by airway inflammation and remodelling; a systematic, longitudinal, steroid intervention study of airway biopsy (ebb) and BAL parameters. Eur Respir J 2002; 20: Suppl. 38, 1927

Member's Comments

No comment yet.

Related content which might interest you: Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study Source: Eur Respir J 2010; 35: 48-53 Year: 2010 What more can we learn from body-box measurements compared with spirometry? Source: Annual Congress 2005 - MP1 - What more can we learn from body-box measurements compared with spirometry? Year: 2005 The effects of body weight on airway calibre Source: Eur Respir J 2005; 25: 896-901 Year: 2005 Reliability, consistency and variability of base-line spirometric and plethysmographic measurements prior to methacholine challenge tests assess airway hyperreactivity (AHR) Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Spirometry, lung volumes, airway hyperresponsiveness, and FeNO measurements: basic principles Source: Annual Congress 2009 - PG11 Paediatric lung function testing - an interactive course Year: 2009 Allergen-induced airway remodelling Source: Eur Respir J 2007; 29: 1020-1032 Year: 2007 Resistive work of breathing (sWOB) as target parameter evaluating methacholine challenge to assess airway hyperreactivity (AHR) in comparison to other lung function parameters Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Changes in airway inflammation, remodelling and PD20 following inhaled corticosteroid treatment are not temporally concordant Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002 Peripheral airway involvement in asthma assessed by single-breath SF6 and He washout Source: Eur Respir J 2003; 21: 1033-1039 Year: 2003 Airway response to deep inhalation (DI) to characterize airway response to methacholine (Mch) in children Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Dose response of continuous positive airway pressure on nasal symptoms, obstruction and inflammation in vivo and in vitro Source: Eur Respir J 2012; 40: 1180-1190 Year: 2012 Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol Source: International Congress 2019 – Airway physiology Year: 2019 Airway wall eosinophilia in severe asthmatic children: predictive values for noninvasive tests Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Bronchial hyperresponsivenes, atopy and BAL eosinophils in persistent middle lobe syndrome (MLS) Source: Annual Congress 2006 - Advances in diagnosis and treatment of pulmonary diseases in children Year: 2006 Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Source: Eur Respir J 2007; 30: 653-661 Year: 2007